Inherited defects in lymphocyte cytotoxic activity

Archive ouverte

Pachlopnik Schmid, Jana | Côte, Marjorie | Ménager, Mickaël | Burgess, Agathe | Nehme, Nadine | Ménasché, Gaël | Fischer, Alain | de Saint Basile, Geneviève

Edité par CCSD ; Wiley -

International audience. The granule-dependent cytotoxic activity of lymphocytes plays a critical role in the defense against virally infected cells and tumor cells. The importance of this cytotoxic pathway in immune regulation is evidenced by the severe and often fatal condition, known as hemophagocytic lymphohistiocytic syndrome (HLH) that occurs in mice and humans with genetically determined impaired lymphocyte cytotoxic function. HLH manifests as the occurrence of uncontrolled activation of T lymphocytes and macrophages infiltrating multiple organs. In this review, we focus on recent advances in the characterization of effectors regulating the release of cytotoxic granules, and on the role of this cytotoxic pathway in lymphocyte homeostasis and immune surveillance. Analysis of the mechanisms leading to the occurrence of hemophagocytic syndrome designates gamma-interferon as an attractive therapeutic target to downregulate uncontrolled macrophage activation, which sustains clinical and biological features of HLH.

Suggestions

Du même auteur

Syndromes hémophagocytaires d'origine génétique

Archive ouverte | Nehme, Nadine | CCSD

International audience. Both the innate and adaptive immune responses use tightly regulated control systems, the complexity of which begins to emerge. The deregulation of one of these mechanisms characterizes the he...

Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11

Archive ouverte | Sepulveda, Fernando | CCSD

International audience. Inherited defects of granule-dependent cytotoxicity led to the life-threatening immune disorder hemophagocytic lymphohistiocytosis (HLH), characterized by uncontrolled CD8 T-cell and macropha...

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).

Archive ouverte | Pachlopnik Schmid, Jana | CCSD

International audience. X-linked lymphoproliferative syndromes (XLP) are primary immunodeficiencies characterized by a particular vulnerability toward Epstein-Barr virus infection, frequently resulting in hemophagoc...

Chargement des enrichissements...